"Colorectal Cancer Stage III "

Long-term low-dose “Celecoxib” treatment can reduce the risk of colorectal cancer recurrence by 20%

#coloncancer @who @mstdnsocial #healthforall #onehealth #cancer

Using “ctDNA” monitoring, micrometastasis of colorectal cancer can be detected 6-12 months earlier.